Lasa Supergenerics informs about disclosure

13 Sep 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Lasa Supergenerics has informed that the Company has been granted patent, by Controller of Patents, for an invention ‘PROCESSES FOR PREPARATION AND PURIFICATION OF 5-CHLORO-2-NITROANILINE’ on 11th Day of September, 2024 for a term of 20 years effective from 19th Day of June, 2020, in accordance with the provisions of Patents Act, 1970. The above information will also be made available on the Company's website: www.lasalabs.com.

The above information is a part of company’s filings submitted to BSE.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×